DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Gao F, Shen H, Wang ZJ, Yang SW, Liu XL, Zhou YJ.
Rationale and design of the RT-AF study: combination of rivaroxaban and ticagrelor in patients with atrial fibrillation and coronary artery disease undergoing percutaneous coronary intervention.
Contemp Clin Trials 2015;
43: 129-132
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.